Mike Morrison discusses the issues that individuals need to consider when looking at pension transfers

Medicines that target specific nerve cells in the brain could reverse poor mental function in people with Down's syndrome, according to new research, Bupa has said.

Helen Morrissey speaks to Anthony Harris about the formation of the Independent Equity Release Advisers Alliance (IERAA) and how it aims to improve the standards of advice offered to many equity release clients

Chris Horlick takes a look at the latest issues in the long term care market

In November, the UK Forum for Genetics and Insurance (UKFGI) published a report which it commissioned from Professor Sandy Raeburn and myself which suggested possible options for improving the genetics moratorium.

With income drawdown complaints on the rise Fiona Tait takes a look at why this may be and attempts to explode some myths around this product.

Some of you will have followed the trials and tribulations of Park Row over the last month or two. Park Row Associates is being wound up, and will be closed for business by the time this article is published.

The launch of PICA's first report into raising awareness of at-retirement options has given the industry food for thought. Helen Morrissey asks how the recommendations will be taken forward

As Progress from Royal Liver reaches its five year milestone, Mike Warr discusses a narrowing of the market's focus with Paul Robertson

David Phillips provides valuable clarification regarding SIPP provider responsibilities